New signaling pathway linked to breast cancer metastasis

Lymph nodes help to fight off infections by producing immune cells and filtering foreign materials from the body, such as bacteria or cancer cells. Thus, one of the first places that cancer cells are found when they leave the primary tumor is in the lymph nodes. The spread of cancer cells to the lymph nodes, lymphatic metastasis, is known to indicate a poor prognosis in many types of cancers; how tumor cells reach the lymph nodes, however, is not well understood.

A new study by Dr. Heide Ford and colleagues at the University of Colorado School of Medicine in Aurora reveals a mechanism underlying this process in breast cancer. Using mouse models, their team found that a protein called SIX1 is a critical player in early stage metastasis, especially lymphatic metastasis. Their study showed that SIX1 induced expression of another protein called VEGF-C, which stimulated the formation of new lymphatic vessels within and near the primary tumor and lymphatic invasion. Strongly supporting a role in human breast cancer, they also showed that the expression of both proteins was correlated in human .

Their work has identified the SIX1-VEGF-C pathway as an important signaling pathway involved in breast cancer metastasis, and the targeting of this pathway could lead to new anti-cancer treatments.

More information: SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer, Journal of Clinical Investigation.

Provided by Journal of Clinical Investigation

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Photodynamic therapy against cancer

Feb 09, 2011

In a new study, published in Science Translational Medicine, researchers at the University of Helsinki, Finland, investigated whether eradicating tumor-associated lymphatic vessels and the tumor cells they c ...

Outsmarting cancer cells: Scientists learn how they spread

Apr 08, 2011

Saint Louis University researchers have identified a novel mechanism to control the traffic of cells and fluid from tissues to lymphatic vessels. It may be possible to harness this mechanism to fight cancer spread from one ...

Recommended for you

Blood biomarker may detect lung cancer

16 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

Oct 20, 2014

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments